PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Vitória da Silva Espindola

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 12, 2026 · JOURNAL ARTICLE

COMPARAÇÃO ENTRE A QUIMIOTERAPIA E O USO DE RIBOCICLIBE ASSOCIADO À HORMONIOTERAPIA NO TRATAMENTO DO CÂNCER DE MAMA

Revista Ibero-americana De Humanidades, Ciências E Educação

An integrative literature review synthesizing evidence from clinical trials and observational studies on ribociclib plus hormone therapy versus chemotherapy in advanced/metastatic breast cancer, confirming established benefit in progression-free survival for endocrine-eligible patients.

Important Confirmatory EvidenceVitória da Silva Espindola Giovana Cunha dos Santos Maria Eduarda Santos de Moraes

Reported

Studies screened474

Studies after initial exclusions…407

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support